REFERENCES
Background Information on MAO-A
Blaschko, Richter, and Schlossman. (1937a) The inactivation of adrenaline. Journal of Physiology. 90,1-17.
Dostert, P., (1994) Can Our Knowledge of Monoamine Oxidase (MAO) Help in the Design of Better MAO Inhibitors?. J Neural Transm, (Suppl) 41: 269-279
Ewins and Laidlaw. (1910). The fate of parahydroxylphenylethylamine in the organism. Journal of Physiology. 41, 78-87.
Grimsby, Chen, Wang, Lan, and Shih. (1991). Human monoamine oxidases exhibit identical exon-intron organization. Pro. National Academy of Science. 88, 3637-3641.
McCauley and Racker. (1973) Seperation of two monoamine oxidases from bovine brain. Molecular Cellular Biochemistry. 1, 73-81.
Pugh and Quastel. (1937) Oxidation of aliphatic amines by brain and other tissues. Biochem Journal. 31,286-291.
Sagara and Ito. (1982) In vitro synthesis of monoamine oxidase of rat liver outer mitochondrial membrane. Biochem. Biophys Res, Comm. 109, 1102-1107.
Schnaitman, Erwin, and Greenawalt. (1967) The submitochondrial localization of monoamine oxidase: an enzymatic marker for the outer membrane of rat liver mitochondria. Journal of Cellular Biology. 32,719-735.
Walker and Williams. (1984) What does the binding of inhibitors reveal about the active site of monoamine oxidase. In: Monoamine Oxidase and Disease: prospects for therapy with reversible inhibitors. pp41-52. Eds. Tipton, Dostert, and Benedetti. Academic Press: Toronto.
Youdim, M.B.H., Riederer, P. (1993) The Relevance of Glial Monoamine Oxidase-B and Polyamines to the Action of Selegiline in Parkinson's Disease. Movement Disorders, 8 (Suppl 1): S8-S13
Genetics of MAO-A
Brunner, Nelen, Zandvoort, Abeling, Gennip, Walter, Kuiper, Ropers, Oost. (1993) American Journal of Human Genetics. V52, 1032-1039.
Cases, Seif, Grimbsy, Gaspar, Chen, Pournin, Muller, Aguet, Babinet, Shih, De Maeyer. (1995, June 23) Science. V268: 1763-1766.
Chen, Hotamisligil,Huang, Wen, Ezzedine, Aydin-Mudderrisoglu, Powell. (1992b) Nucleic Acids Research. V19: 4537-4541.
Hotamisligil, Breakfield. (1991) American Journal of Genetics. V49: 383-392.
Kruesi, Rapoport, Hamburger, Hibbs, Potter, Lenane, Brown. (1990) Archive of General Psychiatry. V47: 419-426.
Behavioral Implications of MAO-A
Bobrov, Shurygin, Krasil'nikov. (1993) Study of the effectiveness of combined use of MAO inhibitors and psychotherapy in the treatment of chronic alcoholism. Journal of Russian & East European Psychiatry. 26(2) 3-11.
Boer, et al. (July,1994) Recent advances in the psychopharmacology of social phobia. Progress in Neuro-Psychopharmacology &Biological Psychiatry. 18(4) 625-645.
Carrasco, J, et.al. (1994, Dec) Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatrica Scandinavica. 90(6) 427-431.
Castrogiovanni, Maremmani, Bongioanni, Marazziti. (1991) Platelet MAO activity and behavioural characteristics in humans. Neuropsychobiology. 23(4) 173-176.
Dilsaver. (1989) Panic disorder. American Family Physician. 39(6) 167-.
Ellis. (May1991) MAO and criminality:identifying an apparent biological marder for anti-social behavior. Journal o fResearch in Crime and Delinquency. 28(2) 227-251.
Gabel, Stadler, Bjorn, Shindledecker, Bowden. (March 1995) Homovanillic acid and MAO in sons of substance-abusing fathers: Relationship to conduct disorder. Journal of Studies on Alcohol.
Mezzich, Tarter, Moss, Yao, Hsieh, Kirisci. (March 1994) Platelet MAO activity and temperament and personality in adolescent female substance abusers. Personality &Individual Differences. 16(3) 417-424.
Potter, et al. (29 August 1991) The pharmacological treatment of depression. The New England Journal of Medicine. 325(9) 633-643.
Priest, Gimbrett, Roberts, Steinert. (1995) Reversible and selective inhibitors of MAO-A in mental and other disorders. Acta Psychiatrica Scandinavica Supplementum. 91(386) 40-43.
Return to Main Page